Who owns COYA THERAPEUTICS INC?
- Ticker: COYA
- CUSIP Number: 22407b108
Tip: Access positions for across all investors
Analyze quarterly positions in Coya Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Coya Therapeutics stock
Who bought or sold COYA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DME Capital Management | 1.6M | $9.4M | 0% | Sep 2025 |
|
| AIGH Capital Management | 975k | $5.7M | -12% | Dec 2025 |
|
| Vanguard Group | 899k | $5.2M | 8% | Dec 2025 |
|
| Alyeska Investment Group | 800k | $4.6M | 100% | Dec 2025 |
|
| CM Management | 350k | $2.0M | 17% | Dec 2025 |
|
| Private Management Group | 280k | $1.6M | 100% | Dec 2025 |
|
| Marshall Wace | 225k | $1.3M | 439% | Dec 2025 |
|
| Geode Capital Management | 198k | $1.1M | 26% | Dec 2025 |
|
| Dauntless Investment Group | 153k | $872k | 200% | Sep 2025 |
|
| JBF Capital | 100k | $580k | 100% | Dec 2025 |
|
| BlackRock | 70k | $399k | 2% | Sep 2025 |
|
| State Street Corporation | 70k | $403k | 45% | Dec 2025 |
|
| Renaissance Technologies | 67k | $388k | 92% | Dec 2025 |
|
| Citadel Advisors | 65k | $372k | 51% | Sep 2025 |
|
| Walleye Trading Advisors | 37k | $215k | 100% | Dec 2025 |
|
| Springbok Capital Management | 36k | $204k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 35k | $202k | 164% | Sep 2025 |
|
| UBS Group | 35k | $203k | 163% | Dec 2025 |
|
| OMERS Administration Corporation | 35k | $200k | 100% | Dec 2025 |
|
| Susquehanna International | 33k | $190k | -33% | Sep 2025 |
|
| Northern Trust | 32k | $184k | -18% | Sep 2025 |
|
| GHP Investment Advisors | 26k | $152k | 0% | Dec 2025 |
|
| Prosperity Wealth Management | 24k | $136k | 16% | Sep 2025 |
|
| GSA Capital Partners | 21k | $120k | 100% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 21k | $118k | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 20k | $113k | 0% | Sep 2025 |
|
| Oppenheimer & Co | 14k | $81k | 100% | Dec 2025 |
|
| Lantern Wealth Advisors | 12k | $66k | 100% | Sep 2025 |
|
| Charles Schwab Investment Management | 10k | $58k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 5.0k | $29k | 100% | Sep 2025 |
|
| IFP Advisors | 3.8k | $22k | 100% | Dec 2025 |
|
| State of Wyoming | 3.3k | $19k | -6% | Sep 2025 |
|
| BFSG | 2.7k | $16k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 1.5k | $9.6k | 0% | Sep 2025 |
|
| Hanson McClain Advisors | 1.0k | $5.7k | 0% | Sep 2025 |
|
| Tower Research Capital | 988.00 | $5.6k | 56% | Sep 2025 |
|
| SBI Securities | 922.00 | $5.3k | 0% | Sep 2025 |
|
| Rockefeller Capital Management | 500.00 | $2.9k | 100% | Sep 2025 |
|
| Steward Partners Investment Advisory | 500.00 | $2.9k | 0% | Sep 2025 |
|
| Harbour Investments | 132.00 | $752.004000 | 100% | Sep 2025 |
|
| Simplex Trading | 119.00 | $0 | 100% | Sep 2025 |
|
Who sold out of Coya Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Jun 2025 | 27k | $153k |
| Atom Investors | Jun 2025 | 20k | $116k |
| Raymond James Financial | Jun 2025 | 2.0k | $11k |